DKSH Partners with Renata to Bring Necessary Medication to Cambodia

Cambodia, Phnom Penh, May 12, 2025 - DKSH Business Unit Healthcare, a strategic partner for healthcare companies seeking to grow their business in Asia and beyond, has signed an agreement with Renata PLC, one of the largest and fastest growing pharmaceutical companies in Bangladesh. As part of the partnership, DKSH will expand Renata’s products including Gastrointestinal Tract, Diabetes, Cardio-Dyslipidaemia, ATB (Antibiotic), Pain-Anti-inflammatory, and Antifibrotic medicines to the Cambodian market.

DKSH Cambodia’s experienced teams and broad distribution network will ensure that Renata’s prod-ucts reach modern and traditional trade, hospitals, clinics, other medical channels, and patients in need nationwide.

Ananta Saha, Head of International Business, Renata PLC, commented: “We are delighted to partner with DKSH to bring our high-quality medication to patients in Cambodia. We are confident in DKSH’s strong nationwide footprint, extensive distribution network, and expertise to further strengthen Renata’s brands and growth in this market.”.

Philip Wray, Vice President of Healthcare at DKSH Cambodia, said: “We are proud to be the trusted and strategic partner of Renata. Through this partnership, we will deliver high-quality medications, aim-ing at enhancing patient outcomes across the Cambodian market. This collaboration underscores our commitment to improving health and quality of life for patients, in alignment with DKSH’s purpose of enriching people’s lives by providing healthcare for all.”.